ADUS vs JNJ · P/E 17, rev $741.0M vs P/E 17, rev $49.37B
Addus HomeCare Corporation (ADUS) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Addus HomeCare Corporation (ADUS) is a medical care facilities company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported ADUS revenue for 2026-06-30 was $741.0M. Net income was $52.7M. ADUS currently screens at market cap $1.75B and trailing P/E 17.3.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
ADUS currently screens at market cap $1.75B and trailing P/E 17.3. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the ADUS and JNJ stock pages for the full models.
Not investment advice.